☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Neuraly Reports the Completion of Patient Enrollment in P-II Study of NLY01 for the Treatment of Parkinson’s Disease
April 19, 2022
PharmaShots Interview: Jon Heinrichs of Sanofi Pasteur & Tonya Villafana of AstraZeneca Shares Insights on Nirsevimab in Healthy I...
April 19, 2022
BeiGene Provides Updates of Tislelizumab in P-III (RATIONALE-309) Trial as 1L Treatment of Recurrent or Metastatic Nasopharyngeal...
April 19, 2022
Daiichi Sankyo and AstraZeneca Report the US FDA Acceptance for Priority Review of Enhertu to Treat HER2 Mutant Metastatic Non-Sma...
April 19, 2022
Amgen Reports Results of ABP 654 (biosimilar, ustekinumab) in P-III Study for the Treatment of Plaque Psoriasis
April 19, 2022
Biocytogen Entered into an Agreement with CtM Biotech to Co-develop TCR-Mimic Antibody-Based Multi-Specific T Cell Engagers for Ca...
April 19, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions